![149730-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/149730-Thumbnail%20Image.png?versionId=LxH5XwrxbZigOZ0QQMvoSYog0Jh790zR&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240521/us-west-2/s3/aws4_request&X-Amz-Date=20240521T031241Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=149990e9903e67b68e2158b5d9711134b281768ecedd35b618f9df4840d05ffb&itok=RkXj1uBM)
![151515-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/151515-Thumbnail%20Image.png?versionId=0VJu6hFxt_XnfnRc0C3ayq5EIaQzKzan&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240516/us-west-2/s3/aws4_request&X-Amz-Date=20240516T174328Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=d6ac2defea11f14f841c88159b230dff1966ebe29b388224998337781f61db17&itok=Ale2iFPQ)
![135560-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/135560-Thumbnail%20Image.png?versionId=Dhq3jUEdS5oL8Q7W7hP4uge89dfQNRY7&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240521/us-west-2/s3/aws4_request&X-Amz-Date=20240521T055959Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=5b5d29f1890495a6a05fb73425bda9d255e82624b679b059238ba584af5752b1&itok=ds6W34ru)
![148500-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/148500-Thumbnail%20Image.png?versionId=125A9Rnxu_gA2DecgxX1e2XCzJ1IsdWR&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240521/us-west-2/s3/aws4_request&X-Amz-Date=20240521T055959Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=7572af49ba67997b9d302951f39dbf2d1d776ad7b3682dfa63839c4615cd46c7&itok=DVCXRfhn)
As life expectancy increases worldwide, age related diseases are becoming greater health concerns. One of the most prevalent age-related diseases in the United States is dementia, with Alzheimer’s disease (AD) being the most common form, accounting for 60-80% of cases. Genetics plays a large role in a person’s risk of developing AD. Familial AD, which makes up less than 1% of all AD cases, is caused by autosomal dominant gene mutations and has almost 100% penetrance. Genetic risk factors are believed to make up about 49%-79% of the risk in sporadic cases. Many different genetic risk factors for both familial and sporadic AD have been identified, but there is still much work to be done in the field of AD, especially in non-Caucasian populations. This review summarizes the three major genes responsible for familial AD, namely APP, PSEN1 and PSEN2. Also discussed are seven identified genetic risk factors for sporadic AD, single nucleotide polymorphisms in the APOE, ABCA7, NEDD9, CASS4, PTK2B, CLU, and PICALM genes. An overview of the main function of the proteins associated with the genes is given, along with the supposed connection to AD pathology.
![131790-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/131790-Thumbnail%20Image.png?versionId=JaTdehWMWXXLn72dOe7.IPR16kaJSqfx&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240521/us-west-2/s3/aws4_request&X-Amz-Date=20240521T055959Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=35e289e9ded33e044954a0f327e0b20eaf0f7fc6c02c9cca9158c63815f92c50&itok=Ql2dkUzO)
![131688-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-07/131688-Thumbnail%20Image.png?versionId=qQf1Vt7fLRp9bJSyvj4F6LfkMBxwjMRM&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240521/us-west-2/s3/aws4_request&X-Amz-Date=20240521T201959Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=3823c19774051305f55c281c247b7509b5b25379d4240225d02b1f00b2675650&itok=gw6w0_vj)
Current advances in cellular models of neurodegenerative diseases overcome a variety of limitations possessed in animal and post-mortem human models. Human-induced pluripotent stem cells (hiPSCs) provide a platform with cells that can self-renew and differentiate into mature and functional cell types. HiPSCs are at the forefront of neurodegenerative disease research because of their ability to differentiate into neural cell types. Apolipoprotein E (ApoE) is a protein encoded by the APOE gene found on chromosome 19 of the human genome. There are three common polymorphisms in the APOE gene, resulting from a single amino acid change in the protein. The presence of these polymorphisms are studied as associated risk factors of developing AD. Different combinations of these alleles closely relate to the risk a patient has in developing Alzheimer’s disease. The risk associated effects of this gene are primarily investigated, however the protective effects are not examined to the same extent.
This research aims to overcome the existing limitations in cell differentiations and improve cell population purity that limits the variables present in the culture. To do this, this study optimized a differentiation protocol by separating and purifying neuronal cell populations to study the potential protective effects associated with ApoE, a risk factor seen in SAD. This platform aims to use a purified cell population to effectively analyze cell type specific affects of the ApoE risk factor, specifically in neurons.
![132624-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/132624-Thumbnail%20Image.png?versionId=iZSfC_6vIVxptwOuem9EnkBuUwzAcLnq&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240529/us-west-2/s3/aws4_request&X-Amz-Date=20240529T100919Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=89ac9eca1a30a8b97fb6dab0a51a1e3d07a82b049a53a21462544ca1718f7310&itok=HATol4eU)
understanding of the disease pathology, more efficacious drug development and
regenerative medicine as a form of treatment. There are limitations with current
transgenic mouse models of Alzheimer’s disease and the study of post mortem brain tissue of Alzheimer’s diseases patients. Stem cell models can overcome the lack of clinical relevance and impracticality associated with current models. Ideally, the use of stem cell models provides the foundation to study the biochemical and physiological aspects of Alzheimer’s disease, but at the cellular level. Moreover, the future of drug development and disease modeling can be improved by developing a reproducible and well-characterized model of AD that can be scaled up to meet requirements for basic and translational applications. Characterization and analysis of a heterogenic neuronal culture developed from induced pluripotent stem cells calls for the understanding of single cell identity and cell viability. A method to analyze RNA following intracellular sorting was developed in order to analyze single cell identity of a heterogenic population
of human induced pluripotent stem cells and neural progenitor cells. The population was intracellularly stained and sorted for Oct4. RNA was isolated and analyzed with qPCR, which demonstrated expected expression profiles for Oct4+ and Oct4- cells. In addition, a protocol to label cells with pO2 sensing nanoprobes was developed to assess cell viability. Non-destructive nanoprobe up-take by neural progenitor cells was assessed with fluorescent imaging and flow cytometry. Nanoprobe labeled neurons were cultured long-term and continued to fluoresce at day 28. The proof of concept experiments demonstrated will be further expanded upon and utilized in developing a more clinically relevant and cost-effective model of Alzheimer’s disease with downstream applications
in drug development and regenerative medicine.
![132709-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/132709-Thumbnail%20Image.png?versionId=Ba4p5L3EHLdS63ZPLzlqahROdg_DnCAn&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240529/us-west-2/s3/aws4_request&X-Amz-Date=20240529T100920Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e525f44fc6a551ac191dd829a2c0c9f35384ed8e2d5e2bcf7814dda0c9544bed&itok=wgv6hNrD)
A variety of different genes have been associated with cell fate. For example, the Nanog/Oct-4/Sox2 network forms the core interaction of a gene network that maintains stem cell pluripotency, and Oct-4 and Sox2 also play a role in the tissue types that stem cells eventually differentiate into. Using the CRISPR/cas9 based homology independent targeted integration (HITI) method developed by Suzuki et al., we can integrate fluorescent tags behind genes with reasonable efficiency via the non-homologous end joining (NHEJ) DNA repair pathway. With human embryonic kidney (HEK) 293T cells, which can be transfected with high efficiencies, we aim to create a three-parameter reporter cell line with fluorescent tags for three different genes related to cell fate. This cell line would provide several advantages for the study of cell fate, including the ability to quantitatively measure cell state, observe expression heterogeneity among a population of genetically identical cells, and easily monitor fluctuations in expression patterns.
The project is partially complete at this time. This report discusses progress thus far, as well as the challenges faced and the future steps for completing the reporter line.